Further, the proteomic sequencing data of 5 pairs of ccRCC tissue samples from our study were also analyzed, and the results showed the protein expression level of TPD52L2 in tumor tissues was still abnormally increased (Figure 3F). This evidence concerns the gene TPD52L2 and nonpapillary renal cell carcinoma.